ClinicalTrials.gg
CompletedNCT00714051Updated Oct 8, 2014Results posted

Fall Prevention Program for Older Adults

A Phase 1/2 interventional study of fall prevention training and Attention Control in Accidental Falls, sponsored by US Department of Veterans Affairs. Completed at 1 site in United States. Open to participants aged 65 Years to 80 Years. Per ClinicalTrials.gov, last updated 2014-10-08.

Sponsored by US Department of Veterans Affairs · Phase 1/2, Interventional, and Prevention

Phase
Phase 1/2
Study type
Interventional
Enrollment
55
Allocation
Randomized
Ages
65 Years to 80 Years
Sex
All
01

Study summary

The purpose of this study is to test the effectiveness of a fall prevention program for older adults. Participants assigned to the intervention group will train weekly on a special treadmill that will simulate tripping. Patients not assigned to the tripping program will walk on a standard treadmill.

Read the detailed description

The purpose of this study is to test the effectiveness of a fall prevention program for older adults. Participants assigned to the intervention group will train weekly on a special treadmill that will simulate tripping. Patients not assigned to the tripping program will walk on a standard treadmill. The training program will last for 4 weeks. Upon completion, participants will complete a test where a trip is simulated. Those assigned to the intervention group will test one additional time as well.

02

Conditions studied

  • Accidental Falls
03

In context

Lead sponsor

US Department of Veterans Affairs is the lead sponsor of 675 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 65-80 yr old,
  • normal reflexes and muscle tone

Exclusion criteria

Exclusion Criteria:

  • lower extremity fracture or surgery last 5 yrs
  • back surgery or disc herniation last 5 yrs
  • noticeable gait impairment,
  • low back pain,
  • decreased disease-related vision,
  • dizziness,
  • history of heart problems,
  • bone mineral density \<.65,
  • mini-mental score \<24
05

Study design

Phase
Phase 1 / Phase 2
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
55 participants (actual)

Study arms

  • Experimental
    Fall Prevention Training

    The falls prevention training group participated in four weekly training sessions on a custom-built treadmill that produced trip-simulating perturbations (movements). While harnessed overhead to prevent actual falls, the treadmill stopped or moved suddenly. The goal for the participant was to try and prevent a fall. Each week, the level of difficulty of the task was increased.

    Behavioral: fall prevention training

  • Active comparator
    Attention Control

    The attention control group participated in four weekly treadmill walking sessions at a self-selected speed.

    Behavioral: Attention Control

Interventions

  • Behavioralfall prevention training

    Training on a specialized treadmill that produced trip-simulating perturbations (movements.

  • BehavioralAttention Control

    Participants walked on a treadmill at a self-selected speed once per week for four weeks.

06

What researchers measure

Primary outcomes

  1. Number of Participants Who Fell on a Tripping Test

    Participants completed a tripping test upon completion of the 4 weeks training period. Participants walked along a platform while harnessed to an overhead rail. Participants walked at a self-selected pace knowing that they will be tripped but do not know how or when the trip will be induced. The trip is induced by an obstruction that deploys from the floor. A decoy rope was laid across the pathway about 3 meters before the trip to intentionally mislead the participant to expect the trip at that point. This expectation affects gait and response to a trip. The participant was tripped on the 3rd set of 10 walking trials.

    Time frame: 4 weeks

07

Results

Posted Oct 8, 2014

Participant flow

Patients were recruited from the general medical clinics, nuclear medicine department and electronic medical record. Letters of invitation were sent to eligible participants. Recruitment began in January 2009 and ended in August 2011. .

Participant flow — Overall Study
MilestoneFalls Prevention TrainingControl
Started2728
Completed2627
Not completed11
Withdrew: Withdrawal by subject10
Withdrew: Death01

Outcome measures

PrimaryNumber of Participants Who Fell on a Tripping Test

Participants completed a tripping test upon completion of the 4 weeks training period. Participants walked along a platform while harnessed to an overhead rail. Participants walked at a self-selected pace knowing that they will be tripped but do not know how or when the trip will be induced. The trip is induced by an obstruction that deploys from the floor. A decoy rope was laid across the pathway about 3 meters before the trip to intentionally mislead the participant to expect the trip at that point. This expectation affects gait and response to a trip. The participant was tripped on the 3rd set of 10 walking trials.

Time frame:
4 weeks
Reported as:
Number · participants
Number of Participants Who Fell on a Tripping Test
participantsFalls Prevention TrainingAttention Control
Number of Participants Who Fell on a Tripping Test24
Statistical analysis
  • Falls Prevention Training vs Attention Control · Chi-squared · p = 0.45

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Falls Prevention Training—0/27 (0%)0/27 (0%)
Attention Control—1/28 (3.6%)0/28 (0%)
Most frequent serious events
Most frequent serious events
EventFalls Prevention TrainingAttention Control
DeathCardiac disorders0/271/28

Baseline characteristics

Age, Continuous
Age, Continuous(years)Falls Prevention Training GroupControl GroupTotal
Mean73.0 ± 4.270.9 ± 4.371.9 ± 4.3
Sex: Female, Male
Sex: Female, Male(Participants)Falls Prevention Training GroupControl GroupTotal
Female224
Male252651
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Falls Prevention Training GroupControl GroupTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American202
White252853
More than one race000
Unknown or Not Reported000
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Falls Prevention Training GroupControl GroupTotal
Hispanic or Latino000
Not Hispanic or Latino272855
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(participants)Falls Prevention Training GroupControl GroupTotal
United States272855
Co-morbidities
Co-morbidities(co-morbidities)Falls Prevention Training GroupControl GroupTotal
Mean2.6 ± 1.63.1 ± 2.22.9 ± 1.9
Bone mineral density
Bone mineral density(gm/cm2)Falls Prevention Training GroupControl GroupTotal
Mean0.94 ± 0.10.90 ± 0.110.92 ± 0.11
Six minute walk
Six minute walk(meters)Falls Prevention Training GroupControl GroupTotal
Mean546 ± 90545 ± 102545 ± 96

3 further baseline measures are reported on the registry.

08

Study locations

1 site
  • Edward Hines, Jr. VA Hospital
    Hines, Illinois 60141-5000, United States
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Oct 2008, a primary completion of Feb 2012 and a completion of Oct 2014. It does not say whether these dates are actual or estimated.

Results were first posted in Oct 2014, 2 years 8 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 8, 2008
First posted
Jul 14, 2008
Start
Oct 2008
Primary completionActual
Feb 2012
CompletionActual
Oct 2014
Results first posted
Oct 8, 2014
Last update
Oct 8, 2014
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 8, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00714051
Responsible party
Sponsor
First posted
Jul 14, 2008
Start date
Oct 2008
Primary completion
Feb 2012
Completion
Oct 2014
Results posted
Oct 8, 2014
Last update
Oct 8, 2014

Study contacts

Eileen G. Collins, PhD RN
principal investigator · Edward Hines Jr. VA Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion